We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
26
Illumina
ILMN
$29.4B
$84.2M 0.7%
243,465
-2
-0% -$816
V icon
27
Visa
V
$677B
$82.9M 0.69%
394,446
WM icon
28
Waste Management
WM
$95.9B
$78.4M 0.65%
692,523
-18
-0% -$2.1K
NVDA icon
29
NVIDIA
NVDA
$5.01T
$76.4M 0.64%
6,092,000
ADSK icon
30
Autodesk
ADSK
$44.3B
$76M 0.63%
259,090
-3
-0% -$865
ADBE icon
31
Adobe
ADBE
$89.5B
$73.6M 0.61%
153,167
+2
+0% +$935
BIO icon
32
Bio-Rad Laboratories Class A
BIO
$8.42B
$73.2M 0.61%
130,772
-3
-0% -$1.78K
PANW icon
33
Palo Alto Networks
PANW
$264B
$73.2M 0.61%
1,287,624
-12
-0% -$713
NKE icon
34
Nike
NKE
$61.9B
$72M 0.6%
529,724
+8
+0% +$1.11K
XLRN
35
DELISTED
Acceleron Pharma
XLRN
$68.4M 0.57%
556,934
-1
-0% -$129
HOLX
36
DELISTED
Hologic
HOLX
$66.9M 0.56%
955,731
-27
-0% -$2.05K
SBUX icon
37
Starbucks
SBUX
$118B
$65.1M 0.54%
633,228
PEP icon
38
PepsiCo
PEP
$186B
$64.3M 0.54%
451,182
-12
-0% -$1.65K
ADI icon
39
Analog Devices
ADI
$181B
$62.1M 0.52%
437,454
-13
-0% -$2K
GOOG icon
40
Alphabet (Google) Class C
GOOG
$3.9T
$61.7M 0.51%
733,720
EQIX icon
41
Equinix
EQIX
$107B
$59.2M 0.49%
86,563
-1
-0% -$686
CRM icon
42
Salesforce
CRM
$134B
$57.5M 0.48%
269,077
+7
+0% +$1.56K
HD icon
43
Home Depot
HD
$332B
$56.9M 0.47%
223,043
-1
-0% -$276
UNH icon
44
UnitedHealth
UNH
$382B
$56.2M 0.47%
163,903
+4
+0% +$1.39K
PDD icon
45
Pinduoduo
PDD
$118B
$56.2M 0.47%
329,200
CSCO icon
46
Cisco
CSCO
$450B
$56.2M 0.47%
1,306,532
UNP icon
47
Union Pacific
UNP
$183B
$56M 0.47%
280,111
-10
-0% -$2.1K
TRMB icon
48
Trimble
TRMB
$12.3B
$55.1M 0.46%
859,058
-6
-0% -$433
ABBV icon
49
AbbVie
ABBV
$458B
$54.6M 0.45%
530,081
+14
+0% +$1.5K
TPTX
50
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$53.5M 0.45%
456,941
-5
-0% -$595

Similar funds

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.